Recently, we developed a risk score for antiphospholipid syndrome (APS)(Global APS
Score or GAPSS). This score derived from the combination of independent risk factors for …

Recently our group introduced the “antiphospholipid score”(aPL-S), a quantitative marker
that represents aPL profile. We have validated its efficacy for the diagnosis of …

Abstract Purpose of Review Antiphospholipid syndrome (APS) is a clinical disorder
characterised by thrombosis and/or pregnancy morbidity in the persistence of …

Objective Recently, our group conceived a risk score for clinical manifestations of APS (the
global APS score, or GAPSS) that takes into account the combination of independent …

Background Antiphospholipid syndrome (APS) is an autoimmune condition that is
diagnosed by the presence of at least one of the clinical manifestations (thrombosis and/or …

Objective. To develop and validate a risk score [global APS score (GAPSS)] derived from the
combination of independent risk for thrombosis and pregnancy loss (PL), taking into account …

Objective The objective of this report is to independently validate the adjusted Global
Antiphospholipid Syndrome Score (aGAPSS) to predict thrombosis in a cohort of patients …

Abstract The adjusted Global Antiphospholipid Syndrome (APS) Score (aGAPSS) is a tool
proposed to quantify the risk for antiphospholipid antibody (aPL)-related clinical …

Objective. The aim of this study was to evaluate the clinical relevance of the global APS
score (GAPSS) in a cohort of primary APS patients. Methods. This study included 62 …

Because the diagnosis of antiphospholipid syndrome is based on laboratory data,
performance and interpretation of such tests is essential. Positivity in a single test among …